Edward H Liao

20130344051, Dec 26, 2013

Aug 28, 2013

14/012629

BENEDICT SCHUE LIAO - MONTEREY PARK CA, US
AUSTIN LEWIS LIAO - FULLERTON CA, US
JUSTIN LIAO - IRVINE CA, US
EDWARD REGEAN LIAO - IRVINE CA, US
ROBERT LIAO - LOS ANGELES CA, US
LILY LIAO - LOS ANGELES CA, US
ALEX BISMARK LIAO - LOS ANGELES CA, US
STANLEY LEO - LAS VEGAS CA, US
NELSON BENSON LEO - LAS VEGAS NV, US

GARFIELD MEDICAL GROUP - MONTEREY PARK CA

A61K 38/48
A61K 31/375

424 943, 435188

A composition of matter can reduce size of cancerous tumors in mammals. The composition of matter comprises Bromelain infused with vitamin C creating a protein enzyme complex which can be administered in an effective amount to reduce the size of cancerous tumors in mammals.

20130236445, Sep 12, 2013

Dec 16, 2011

13/374328

Benedict Schue Liao - Los Angeles CA, US
Alex B. Liao - Los Angeles CA, US
Austin Lewis Liao - Los Angeles CA, US
Burton Arthur Liao - Los Angeles CA, US
Justin Liao - Irvine CA, US
Edward Regean Liao - Irvine CA, US
Robert Liao - Los Angeles CA, US
Lily Liao - Los Angeles CA, US
Stanley Leo - Las Vegas NV, US
Ludwig Schue Liao - Baltimore MD, US

Garfield Medical Group - Monterey Park CA

A61K 38/48

424 9465

A method for treating and/or preventing various types of human cancer and neoplastic diseases which is comprised of the administration thereto of an effective amount of Bromelain extract derived from and such proteins as ananase, bromelain, comosain, extranase, Inflamen, traumanase, and/or a mixture thereof.

20230103457, Apr 6, 2023

Jun 29, 2022

17/853708

- Santa Monica CA, US
Eugene Bolotin - Berkeley CA, US
Alexander S. Falk - Thousand Oaks CA, US
Edward H. Liao - Petaluma CA, US

G16B 20/20
C12Q 1/6869

A method for ensuring that gene products used in cell therapy do not carry a risk of reduced efficacy or toxicity due to production of unintended variants. The method includes performing an in-silico analysis on the gene construct to identify and alter sequences likely to cause variants. Also, the method includes performing an in-vivo analysis consisting of RNA-sequence of construct based products. Variant detection may then be performed based on gapped reads from the RNA-sequence to determine variant expression levels, variant significance. The method may include repeating the in-silico analysis if identified variants are unacceptable.

20230013874, Jan 19, 2023

May 23, 2022

17/751266

- Santa Monica CA, US
Jodi Murakami - Culver City CA, US
Samuel T. Haile - Castro Valley CA, US
Edward H. Liao - Petaluma CA, US

A61K 35/17
C07K 14/725
A61P 35/00
C12N 15/85
C12N 5/0783

Provided are chimeric antigen receptors (CARs) comprising an NGK2D ecto domain. Provided are compositions, cells and cell therapies comprising the same. Further provided are methods of treatment.

20180060278, Mar 1, 2018

Sep 1, 2016

15/255015

- San Diego CA, US
Edward LIAO - San Diego CA, US
Somdeb MAJUMDAR - Mission Viejo CA, US
Aaron LAMB - San Diego CA, US
Karamvir CHATHA - San Diego CA, US

G06F 17/17

Computing a non-linear function ƒ(x) in hardware or embedded systems can be complex and resource intensive. In one or more aspects of the disclosure, a method, a computer-readable medium, and an apparatus are provided for computing a non-linear function ƒ(x) accurately and efficiently in hardware using look-up tables (LUTs) and interpolation or extrapolation. The apparatus may be a processor. The processor computes a non-linear function ƒ(x) for an input variable x, where ƒ(x)=g(y(x),z(x)). The processor determines an integer n by determining a position of a most significant bit (MSB) of an input variable x. In addition, the processor determines a value for y(x) based on a first look-up table and the determined integer n. Also, the processor determines a value for z(x) based on n and the input variable x, and based on a second look-up table. Further, the processor computes ƒ(x) based on the determined values for y(x) and z(x).

20150269480, Sep 24, 2015

Jun 9, 2014

14/300019

- San Diego CA, US
Erik Christopher MALONE - San Diego CA, US
Edward Hanyu LIAO - San Diego CA, US

G06N 3/08

Certain aspects of the present disclosure support a method and apparatus for implementing kortex neural network processor within an artificial nervous system. According to certain aspects, a plurality of spike events can be generated by a plurality of neuron unit processors of the artificial nervous system, and the spike events can be sent from a subset of the neuron unit processors to another subset of the neuron unit processors via a plurality of synaptic connection processors of the artificial nervous system.

20150170027, Jun 18, 2015

Oct 28, 2014

14/526304

- San Diego CA, US
Jeffrey Alexander LEVIN - San Diego CA, US
Edward Hanyu LIAO - San Diego CA, US

G06N 3/08

A method for providing diversity in a set of neurons in a neuron model includes retrieving a set of parameters for the set of neurons. The method also includes perturbing the set of parameters based on a neuron identification value, a level of perturbation for each parameter and/or parameter values.

20150170028, Jun 18, 2015

Oct 28, 2014

14/526317

- San Diego CA, US
Jeffrey Alexander LEVIN - San Diego CA, US
Edward Hanyu LIAO - San Diego CA, US

G06N 3/08

A method for pattern recognition in a spiking neural network robust to initial network conditions includes creating a set of diverse neurons in a first layer to increase a diversity in a set of spike timings. An input corresponding to a pattern plus noise is presented at an input layer and represented as spikes. The spikes are received at the first layer and spikes are produced at the first layer based on the received spikes. The method also includes updating a weight of each synapse between an input layer neuron and an output layer neuron based on a spike timing difference between a spike at the input layer neuron and a spike at the output layer neuron. Further, the method includes classifying a spike pattern represented by a set of inter-spike intervals, regardless of noise in the spike pattern.